Work

Efficacy and Safety of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naive, Higher-Risk Myelodysplastic Syndromes

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-189446

Authors: Jacqueline S. Garcia, Uwe Platzbecker, Olatoyosi Odenike, Shaun Fleming, Chun Yew Fong, Rachel Cook, Meagan Jacoby, Daniel Nowak, Brenda Chyla, Ying Zhou, Grace Ku, Jalaja Potluri, Guillermo Garcia-Manero

Institutions: Harvard University, Dana-Farber Cancer Institute, University Hospital Leipzig, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, The Alfred Hospital, Alfred Health, Austin Health, Oregon Health & Science University, Washington University in St. Louis, Heidelberg University, Medizinische Fakultät Mannheim, AbbVie (United States), Genentech, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389230978

Cites:

Cited by: 11

Related to: 10